Securities code: Sirio Pharma Co.Ltd(300791) securities abbreviation: Sirio Pharma Co.Ltd(300791) announcement Code: 2022014 securities code: 123113 securities abbreviation: xianle convertible bonds
Indicative announcement of annual report disclosure in 2021
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
The board of directors of Sirio Pharma Co.Ltd(300791) (hereinafter referred to as “the company”) held the seventh meeting of the third board of directors on April 8, 2022, at which the proposal on reviewing the annual report and summary of 2021 of the company was deliberated and adopted; The board of supervisors of the company held the sixth meeting of the third session of the board of supervisors on April 8, 2022. The meeting deliberated and adopted the company’s proposal on reviewing the annual report and summary of 2021.
In order to enable investors to fully understand the company’s operating results and financial status in 2021, the company’s annual report 2021 and its abstract were disclosed on the gem information disclosure website designated by the CSRC on April 12, 2022. Please pay attention to it.
It is hereby announced.
Board of directors
April 12, 2002
